http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2007114467-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20 |
| filingDate | 2007-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2007114467-A |
| titleOfInvention | METHOD FOR TREATING LOCAL DISTRIBUTED AND GENERALIZED LUNG CANCER |
| abstract | A method for treating locally advanced and generalized lung cancer, including chemotherapy, characterized in that patients have bone marrow taken from the posterior superior iliac crest in a volume of 150-180 ml, incubated at 37 ° C for 24 hours with 1 million IU roncoleukin (IL-2), then autohemochemotherapy (AHCT) is carried out together with automyeloimmunotherapy (AMIT) cultured bone marrow cells with roncoleukin (IL-2) according to the scheme and in the following modes: for small cell cancer: cisplatin - 80 mg / mv 1st day, vepezid - 120 mg / mv 1st, 2nd, 3rd day, roncoleukin - 1 million IU on the 2nd, 3rd, 4th, 5th day; for non-small cell cancer: cisplatin - 80 mg / mv on the 1st day, vepezid - 120 mg / mv on the 1st, 3rd, 5th day, roncoleukin - 1 million IU in the 2nd, 4th, 6th 1st, 7th day, drugs are administered intravenously, 2 courses of treatment with an interval of 3 weeks. |
| priorityDate | 2007-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441203 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535155 |
Total number of triples: 15.